Kursprognose für Rein Therapeutics Inc (RNTX)

$0.614

+0.002 (+0.28%)Zum Schluss

Kursprognosen

1-Day Price Prediction

-1.86%

1-Week Prediction

-0.70%

1-Month Prediction

—

2026 Prediction

—

2030 Prediction

—

In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.

Loading chart…

RNTX-Prognose durch Analyse ähnlicher Charts

Alphio's RNTX stock price prediction model matches the current Rein Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.60 (-1.86%). The 1-week path is $0.61 (-0.70%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Soll ich Rein Therapeutics Inc-Aktien kaufen?

Rein Therapeutics, Inc. (RNTX) appears to be a good buy right now due to its recent positive developments, including receiving FDA Fast Track designation for its drug LTI-03, which addresses a significant unmet need in idiopathic pulmonary fibrosis. The stock is currently priced at $0.64, significantly below its 52-week high of $2.18, indicating potential for recovery. Additionally, the stock has shown a 5-day change of +8.95%, suggesting a recent upward momentum. However, the main risk is its negative earnings per share (EPS) of -0.10 expected in the upcoming earnings report, which could impact investor sentiment.

RNTX schloss am Friday bei $0.61, nachdem der Kurs +0.28% gestiegen ist

Rein Therapeutics Inc (RNTX) last closed at $0.6137, gaining +0.28%. These facts feed the 1-day and 1-week RNTX price prediction above.

Prognose-Treiber

Die Prognose-Treiber von Rein Therapeutics Inc (RNTX) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Negative

Bearish

Saisonalitätsanalyse für RNTX

Historically the probability of a positive November return for RNTX is 22.73%. April offers the highest probability of a positive month at 64.06%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…